Brief: Frequency Therapeutics - Q1 Revenue Of $4.7 Mln
13/05/2021 13:04
May 13 (Reuters) - Frequency Therapeutics Inc FREQ.O :
* Q1 REVENUE ESTIMATE $8.1 MILLION -- REFINITIV IBES DATA
* QTRLY LOSS PER SHARE $0.60
Source text for Eikon: ID:nBw4sjmJVa
Further company coverage: FREQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Korro Bio
See all newsBrief: Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Korro Announces First Cohort Dosed In Phase 1/2 Clinical Trial (Anchor) For Krro-121
Brief: Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Korro Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Korro Bio, Inc. expected to post a loss of $1.43 a share - Earnings Preview